Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,030 stories, page 492 of 701

Advanced search

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

U.S. Senators Look to Investigate Foreign Influence on U.S. Pharmaceutical Supply Chains

NAVLIN DAILYOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

ASU, Callan JMB Partnership Poised to Transform Marion into National Pharmaceutical Hub

Alabama State UniversityOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Supply Chain Signal: Domestic Manufacturing and the German Pricing Standoff

Pharmaceutical CommerceOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA approves first cholesterol pill to match powerful injectable drugs

YnetnewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Lifera leads Saudi Arabia's push to become global biotech hub

BioProcess InternationalOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA Grants Traditional Approval to Novartis's Fabhalta | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Kibow® Biotech Honored with The American Association of Naturopathic Physicians Corporation of the Year Award

PR NewswireOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

GSK shelves cough therapy added from $2B Bellus buyout after trial failure

MSNOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

U.S. Biotech Sector Must Reject MFN to Beat China: Expert Op-ed

NAVLIN DAILYOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

TipRanksOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Nuvation Bio Moves Safusidenib Into Phase 3, Raising Stakes in Targeted Brain Cancer

TipRanksOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Where To Invest Now In AI, Biotech, Small Caps, And Gold

Seeking AlphaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval

BenzingaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Form 144 COLLEGIUM PHARMACEUTICAL For: 17 July By Investing.com

Investing.com CanadaOriginal source

🌍Jul 18Regulatorywho.intTier 1 · Regulatory source

Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda

WHO Disease Outbreak NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

BRIGHT PATH CONGRATULATES KHONA SCIENTIFIC'S INVESTMENT In STRENGTHENING AMERICA'S PHARMACEUTICAL SUPPLY CHAIN

EIN NewsOriginal source

🌍Jul 18discoverynews.google.comTier 2 · Trade media

BlossomHill eyes IPO to grow taller in crowded cancer fields

Fierce BiotechOriginal source

🌍Jul 18discoverynews.google.comTier 2 · Trade media

Bayer’s heart failure drug bound for NHS on NICE recommendation

Pharmaceutical TechnologyOriginal source

🇺🇰Jul 18Regulatorygov.ukTier 1 · Regulatory source

JCVI statement on meningococcal B vaccination in older children and young adults, 16 July 2026

Statement setting out the recommendation from the Joint Committee on Vaccination and Immunisation (J...

UK Department of Health and Social CareOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

China Pharmaceutical Innovation Conference (CPIC)

Foley HoagOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Expands with $2.8B Psychedelic Acquisition

Investing News NetworkOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'

Marijuana MomentOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA raised conflict of interest concerns ahead of new peptide panel

The Washington PostOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Forum exposes gaps in regulatory ecosystem

The Manila TimesOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Novartis wins full FDA approval for kidney disease drug Fabhalta in IgA nephropathy

Seeking AlphaOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Summit Therapeutics Refocuses on Oncology Drug After Antibiotic Sale

Streetwise ReportsOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

GSK shelves cough drug acquired in $2B deal

BioPharma DiveOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Study expects plasticware use to increase

Scientist LiveOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Cloudbreak Pharma Inc. Announces Completion Of Safety Review By The FDA For CBT-358 Investigational New Drug Application

marketscreener.comOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Fact check: Claims linking statins to dementia are false

DW.comOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Raphael Pharmaceutical Inc. Announces Chief Financial Officer Changes, Effective July 16, 2026

marketscreener.comOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

BIO San Diego 2026 Executive Interviews

Fierce BiotechOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Trevi Therapeutics Shares Surge 13% as Biopharma Investors Cheer Cough Drug Data at London Conference

International Business Times AustraliaOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

Jasper Therapeutics

Fierce BiotechOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

What Teva Pharmaceutical Industries (TEVA)'s TEV‑408 Vitiligo Data and Funding Deal Means For Shareholders

simplywall.stOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Ion-Pair Reagents Market Growth Trajectory to 2035: Analytical Chemistry Demand Accelerates - News and Statistics

IndexBoxOriginal source

🇫🇷Jul 17Researchchru-strasbourg.frTier 2 · Direct publisher

Une semaine au cœur de l’excellence du prélèvement multi-organes

Hôpitaux Universitaires de StrasbourgOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

FDA Juggernaut Marches On, 110-Year Old Parsi Dairy Farm’s Licence Suspended

English Bombay SamacharOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Disappointing Data Prompts GSK to Drop Cough Drug Development - GSK (NYSE:GSK)

BenzingaOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

The end for GSK’s chronic cough treatment

STATOriginal source

🌍Jul 17discoverynews.google.comTier 1 · Regulatory source

Commissioner's National Priority Voucher (CNPV) Pilot Program

fda.govOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

GSK’s drops chronic cough drug, dampening $2bn Bellus Health bid

Clinical Trials ArenaOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Siya Goyal's father clarifies after FDA action on shop: 'Not sealed but I am being punished'

MSNOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

New effort can help beat China in biotech race — if RFK Jr. doesn’t hold it back

Washington ExaminerOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Inside the UK-US Pharmaceutical Supply Chain Deal

Supply Chain DigitalOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

J&J’s Mark Graham on advancing nipocalimab as treatment for SLE

Pharmaceutical TechnologyOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador

Fierce BiotechOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

Tagrisso-chasing BlossomHill enters Nasdaq queue as biotech IPOs flourish

Endpoints NewsOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

APhA urges FDA to put patient safety first in review of peptide substances

Yahoo Finance SingaporeOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Health news round-up: vaccination, testosterone and neighbourhood health

The Pharmaceutical JournalOriginal source

🌍Jul 17discoverynews.google.comTier 2 · Trade media

Fierce Pharma Asia—GSK, Merck ADCs’ trial wins; AZ’s $1.5B EGFR buy; Biotechs’ new patent tricks

Fierce PharmaOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Mumbai's 110-Year-Old Parsi Dairy Farm Loses Food Licence After FDA Inspection

Local SamosaOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Manufacturing ChemistOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Raphael Pharmaceutical (RAPH) names new CFO as chairman and CFO resign

Stock TitanOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Biotech Growth says Eli Lilly's $2.8bn swoop on AtaiBeckley underlines the value of smaller drug developers

QuotedDataOriginal source

🇺🇰Jul 17Regulatorygov.ukTier 1 · Regulatory source

Alternative Provider Medical Services (APMS) Directions

Directions for the NHS from the Secretary of State for Health and Social Care relating to Alternativ...

UK Department of Health and Social CareOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Cencora's Brent Wilhelm on the Inventory Paradox Behind Drug Shortages

Pharmaceutical CommerceOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) Could Be 60% Undervalued Following CARVYKTI Sales Update

simplywall.stOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Merck's Breakthrough: First Oral Cholesterol Drug Approved

DevdiscourseOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

DXB boosts drug pipeline and funding runway

The AustralianOriginal source